Publications

The efficacy of photochemical treatment with amotosalen HCI and ultraviolet A (INTERCEPT) for inactivation of Trypanosoma cruzi in pooled buffy-coat platelets. Castro E, Girones N, Bueno JL, Carrion J, Lin L, Fresno M.  Transfusion. 2007; 47:4.

Leukoreduced buffy coat-derived platelet concentrates photochemically treated with amotosalen HCI and ultraviolet A light stored up to 7 days: assessment of hemostatic function under flow conditions. Lozano M, Galan A, Mazzara R, Corash L, Escolar G. Transfusion. 2007;47:666

Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination.  Sawyer L, Hanson D, Castro G, Luckett W, Dubensky T, Stassinopoulos A.  Transfusion. 2007;47:1062-1070.

Prevention of transfusion of platelet components contaminated with low levels of bacteria: a comparison of bacteria culture and pathogen inactivation methods.  Nussbaumer W, Allersdorfer D, Grabmer C, et al.   Transfusion. 2007;47:1125-1133.

Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006.)  Eder A, Kennedy J, Dy B, Notari E, Weiss J, Fang C, Wagner S, Dodd R, Benjamin R, and the American Red Cross Regional Blood Centers.  Transfusion;47:1134-1142.